Recent Updates
Total 14406| § 661.100. Newborn Screening Registries |
| New | Updated: 03/28/2023 |
| § 661.110. Early Hearing Detection and Intervention (EHDI) Registry |
| New | Updated: 03/28/2023 |
| § 661.120. Confidentiality and Access to Data in Newborn Screening Registries |
| New | Updated: 03/28/2023 |
| § 661.130. Data Submission |
| New | Updated: 03/28/2023 |
| § 661.140. Provider Sites |
| New | Updated: 03/28/2023 |
| § 661.150. Individual User Agreement |
| New | Updated: 03/28/2023 |
| § 661.20. Incorporated and Referenced Materials |
| New | Updated: 03/28/2023 |
| § 661.200. Collection and Submission of Specimens |
| New | Updated: 03/28/2023 |
| § 661.210. Blood Spot Reporting |
| New | Updated: 03/28/2023 |
| § 661.220. Retention of Specimens |
| New | Updated: 03/28/2023 |
| § 661.230. Designation of Medical Specialists |
| New | Updated: 03/28/2023 |
| § 661.30. General Procedures for the Newborn Screening |
| New | Updated: 03/28/2023 |
| § 661.300. Adrenoleukodystrophy (ALD) |
| New | Updated: 03/28/2023 |
| § 661.310. Biotinidase Deficiency |
| New | Updated: 03/28/2023 |
| § 661.320. Congenital Adrenal Hyperplasia (CAH) (Secondary to 21-hydroxylase deficiency) |
| New | Updated: 03/28/2023 |
| § 661.330. Congenital Hypothyroidism (CH) |
| New | Updated: 03/28/2023 |
| § 661.340. Cystic Fibrosis (CF) |
| New | Updated: 03/28/2023 |
| § 661.350. Galactosemia |
| New | Updated: 03/28/2023 |
| § 661.360. Lysosomal Storage Disorders (LSDs) |
| New | Updated: 03/28/2023 |
| § 661.370. Amino Acid, Organic Acid and Fatty Acid Oxidation Disorders |
| New | Updated: 03/28/2023 |